Introduction Interstitial lung diseases are the major cause of mortality in connective tissue diseases.Objectives Our aim is to describe patients with interstitial lung disease associated with connective tissue diseases (CTD-ILD) in the Chest Clinic, Colombo 08.
MethodsWe conducted a descriptive cross-sectional study at the Central Chest Clinic, Colombo, Sri Lanka and data of all patients attending the Clinic were analysed.
ResultsThe sample consisted of 83 consecutive patients diagnosed with CTD-ILD. The age ranged from 24 to 72 years with mean (SD) age of 55.6 (10.6) years. The majority was female patients (n=70, 88.6%). The majority 53.0% (n=44) had RA and SSc was the second commonest CTD-ILD (n=22, 26.5%). NSIP 51(61.9%) was the most frequently observed HRCT pattern in our cohort whereas UIP was the second commonest.RA-ILD subgroup demonstrated female (n=37, 86.0%) preponderance. NSIP (n=24, 55.8%) was the commonly observed HRCT pattern followed by UIP (n=15, 34.9%) pattern. Among RA-ILD patients, 28 (65.1%) had positive Rheumatoid factor. Majority of (n=20, 90.9%) SSc-ILD were females. Sixteen (72.7%) of them had NSIP pattern in HRCT analysis followed by UIP (n=6, 27.3%).Conclusion RA-ILD was the most frequent type of CTD-ILD followed by SSc. More importantly; the present study revealed the predominant NSIP pattern and clear female preponderance in RA-ILD compared to global data. We recommend prospective multicenter studies to be carried out and prospective disease registries to be established to explore the epidemiological, clinical, radiological and prognostic characteristics of CTD-ILD in Sri Lanka.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.